current user: public
If you have questions about the server, please let us know.

Query: [S] COG5291 Predicted membrane protein, from VFDB

Results of FFAS03 search in PfamA32U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .
# Score Template Links and tools%idFirst MPSIPQMNNTFLLGQMLRVPPITRYMTLLISAVALLVYVDAVSPYSLYYSPLFLKRLEIWRVFTSFLYFGKPTLDMFMHVVFLYRYSRMLEEGCVNTSEYFWLILVISSVLFAISNIYGISALGTSFSATITYIWTKRNPRAIVQIFGFISFPAFYLPFILPGFMLLSRRSISIDDVLGIVVGHLFHYFKDVYPRWGRDILSTPCWVKKLFNEHPSSCCKARKGITIREGRERHERNMGYSNASTTSGDSMASLTDMADTKSSTENSAVTEESQCCAESFKDSSVVSSQKSMAVSTVVGSSTEAKNNYLDFTEALCDKEVVAEQNPESQSNEEWDEKWGDSDNESECSLast
1 -84.700PF04511.15; DERL1_CAEEL/10-202; Der1-like family  ali follow..  26  1..................IPIVTRYWFLASTIIPLLGRFGFINVQWMFLQWDVVNKFQFWRPLTALIYYPVTPFHWLMMCYFLYNYSKALESETYRSADYLFMLIFNWFFCSGLCMALDIYFLLEPMVISVLYVWCQVNKDTIVSFWFGMRFPARYLPWVLWGFNAVLRGG-GTNELVGILVGHAYFFVALKYPDYGVDLISTPE............................................................................................................................................... 193
2 -22.000PF01694.22; O83947_TREPA/47-200; Rhomboid family  ali follow..  13  1....................................................VRYHRMYWQIFTYQFVHSGV-WHLLFNMLGLVFFGQTIEKKMGSSEMLLFYLLVGTLCGAGACAAYLCLLGASGSIFAILFLFSVMFPTALIYLWGVIPIPAPLLIVGYILFEIFDDNVSHLTHLLGVLFAWGYIRI............................................................................................................................................................... 148
3 -18.200PF03247.14; H3AKK6_LATCH/2-103; Prothymosin/parathymosin family  ali follow..  9  1......................................................................................................................................................................................................................................................SDAAADTTEEVSTKDLKEKISGKEKSEPGAETTDVNGEEEENGAEADEETPEKLNDEDEGDEEDEEEVDDEEEEDEEDEEEGQAVKRRADDDDNTGKKKQKT 102
4 -15.400PF14797.6; H0UU13_CAVPO/860-983; Serine-rich region of AP3B1, clathrin-adaptor complex  ali follow..  17  7..............................................................................................................................................................................................................................................SESEEEEDSSDSSSDSESESESESGEDSMDSSEDSSEESSSEQNSESGSATEAEDKAPTKRSSETRGKSDSEDGKKKNKKSKTSDSSNAESSSVEESSSESESESESESE 116
5 -15.100PF07133.11; Q8IJ54_PLAF7/184-370; Merozoite surface protein (SPAM)  ali follow..  8  4...................................................................................................................................................................................................................FGGGAPQNGAAEDKKTEYLLEQIKIPSWDRNNIPDENEQVIEDPQEDNKDEDEDEETETENLETEDDNNEEIEENEEDDIDEESVEEKEEEEEKKEEEEKKEEKKEEKKPDNEITNEVKEEQKYSSPSDINAQNLIS 140
6 -14.900PF04702.12; VCLB_GOSHI/29-173; Vicilin N terminal region  ali follow..  6  1...........................................................................................................................................................................................................PGRRGDDDPPKRYEDCRRRCEWDTRGQKEQQQCEESCKSQYGEKDQQQRHRPEDPQRRYEECQQECRQQEERQRPQCQQRCLKRFEQEQQQSQRQFQECQQHCHQQEQRPERKQQCVRECRERYQENPWRREREEEAEEEETE.. 143
7 -14.700PF11600.8; H2VC85_TAKRU/240-396; Chromatin assembly factor 1 complex p150 subunit, N-terminal  ali follow..  5  1....................................................................................................................................................................................................................RRSLKSLQEQEERLRLQQEKQRQKEEAKAVKEKKKEEARKIKEERQREKREKKEKEERERREKKEKDEKEKAERLKAKEDLKKSKLEAKQEEKRKKEEEKRMKEEEKRLKEEKDRLKAEKAEITRFLQKSKIQQAP 136
8 -14.600PF12446.8; Q4E5X5_TRYCC/136-277; Protein of unknown function (DUF3682 topsan)  ali follow..  8  6...................................................................................................................................................................................................................GAGSVSSGSSEGPSAPPVAPPVASPAPPGTSGGPSASVDATVVDTSAGRSGGTAGSPGTNPSNTIGDSQTEDQTPAAEANDSSLPEGAAGTTSGTEHTRKEEEEEEEENEKQQQSDETQVQQQQQHEHPAESGEESA 142
9 -14.600PF00477.17; SLE1_SOYBN/1-109; Small hydrophilic plant seed protein  ali follow..  10  2...............................................................................................................................................................................................................................................ESQQANREELDEKARQGETVVPGGTGGKSLEAQEHLAEGRSRGGQTRKQQLGSEGYHEMGTKGGQTRKEQMGREGYQEMGRKGGLSTMDKSGGERAEEEGIEIDESK.. 108
10 -14.300PF16009.5; H9JW12_BOMMO/205-364; Domain of unknown function (DUF4779 topsan)  ali follow..  6  1.....................................................................................................................................................................................................................TQGGGHANLGNHHAEHGGKTTKGFSTDHFVDKGGKGYKTDEHHRKEYEDAGGNKKKHHDHAGHQGSHEEEAHGSRGSHFGEKKGHKKGHKTKGYHNKYHKDEFHKEHKFYDDFHKSGEHHRYGKFHAKHASNESG 135
11 -14.100PF07376.11; M1CYC0_SOLTU/1-202; Prosystemin  ali follow..  7  2...........................................................................................................................................................................................................................................ETPSYDIKNKGDDMQEELKVKLHHEKGGDEKEKIIEKETPSQDIKNKDTITSYVLRDDAPEIPKVEHEEGGDGKEKIVEKETISKCIIKIEGDDAQEKLKVEYEEEEYEKEKI 114
12 -14.000PF12718.7; Q6C081_YARLI/7-149; Tropomyosin like  ali follow..  6  1............................................................................................................................................................................................................................................................KMNSLRLETDAAQEKADEALEKVKAQEQELLQKDHEIQALTHKNSLLEEEVEKLEQQLSESKDAAEEGATHGAANEGLSKKLAILEEDLENSDRNL 96
13 -13.900PF04538.12; H0W9V3_CAVPO/1-176; Brain expressed X-linked like family  ali follow..  8  10...................................................................................................................................................................................................................GKPEKERKAEDKLEPDDEGKIEKEEKTDHEGKPAFEGKLEGEGEPNVERQGKNEGKPEMQSKLGDEGSPQGEGNAESQARPENKQLPAEKHLAEDYVPRKAKRKTDRGTEDSPKDSQENLQDTHLSREEMMREFADM 146
14 -13.800PF06495.11; Q9NIJ7_DROAE/1-186; Fruit fly transformer protein  ali follow..  7  1..................................................................................................................................................................................................................MDADSSSRSPRDTRRRPRQREKMPYFADELRERDRVRNLRKLKTTQKRTPTPPPRERRSRQARSRSRSRTHSAEQSRCQRRRSRSYVRQRSGSRHQTSSSCSRRRHSRSRSRSRTPRIITVPVPVPAAEYSSYAYGWP 138
15 -13.700PF16228.5; Q5HQV7_STAEQ/24-195; Domain of unknown function (DUF4887 topsan)  ali follow..  6  36...................................................................................................................................................................................................................DKKSVEEKKNNTQQTQQVPQTQQTQQTQQTVQTPQRPTTQTPVRQNPQTGEKRAKEPKTDERKKTRQDSSNSKESPNEKDQSSTQQKPQQNKSNQSSENRQSTQNKSNQTQSTRPQNNGNSGNQNASSGQNTQKQNN 172
16 -13.600PF06614.11; F7FEE8_MACMU/67-238; Neuromodulin  ali follow..  8  36...................................................................................................................................................................................................................GKAGETPSEEKKGEGDAATEQAAPQAPASSEEKAGSAETESATKASTDNSPSSKAEDAPAKEEPKQADVPAAVTAAAATTPAAEDAAAKATAQPPTETGESSQAEENIEAVDETKPKESARQDEGKEEEPEADQEHA 172
17 -13.200PF16599.5; W5N2F8_LEPOC/1164-1347; Unstructured linker region on PTN13 protein between PDZ  ali follow..  5  25...................................................................................................................................................................................................................PGQRQKQDDESSSEEHNRAPSCSRPASGGSATVSLSRQNGSMSSQDSRTESASLSQTIINGFHKKQVPDGAAPLPSCHPENAVTSDTPAPALPPKTWKGRIPEIVKDQYDSDRGDSDMDEDTCSSSQEKQMSKGLSP 161
18 -12.900PF00985.17; MSA2_PLAF7/102-272; Merozoite Surface Antigen 2 (MSA-2) family  ali follow..  5  1...................................................................................................................................................................................................................TTTTTTTNDAEASTSTSSENPNHKNAETNPKGKGEVQEPNQANKETQNNSNVQQDSQTKSNVPPTQDADTKSPTAQPEQAENSAPTAEQTESPELQSAPENKGTGQHGHMHGSRNNHPQNTSDSQKECTDGNKENCG 137
19 -12.900PF01101.18; H0XSH6_OTOGA/1-95; HMG14 and HMG17  ali follow..  11  3........................................................................................................................................................................................................................................................................KGKVSSAQGAGKEEPKRRSARLSAKPAPATVETQPKKAAARGESSDKKVQPKGKRGVKGKPDVVANGETKDLPAENGETKTKEN 86
20 -12.700PF06513.11; Q25920_PLAFA/526-740; Repeat of unknown function (DUF1103 topsan)  ali follow..  5  25...................................................................................................................................................................................................................SEKTQKEIKEKVEKRVKKKCKKKVKKGIKENDTEGNDKVKGPEIIIEEVKEEIKKQVEDGIKENDTEGNDKVKGPEIITEEVKEEIKKQVEDGIKENDTEGNDKVKGPEIITEEVKEEIKKQVEEGIKENDTEGNDK 161
21 -12.500PF15971.5; D2RW44_HALTV/57-219; DolP-mannose mannosyltransferase  ali follow..  8  5...........YVDVWDVNPPVPFAITAALAVLSGGNMYVLHGLSVILTLLVAAANILLVGWVAFLVTGEDAAAVAAGLTMLVVPELFLLPLAGVWAQFYALFFGVLSLALAL-----RDRPFLAGVAAALSAGSWQSG--------------IAFAPLVVGMTYQRTGGKDVLRAIAGGGVVTGVVVL............................................................................................................................................................... 163
22 -12.400PF15620.6; L8YCT1_TUPCH/224-477; Centromere assembly component CENP-C middle DNMT3B-binding region  ali follow..  8  68...................................................................................................................................................................................................................HSHGAHPVEKSQPSDQENLCTNCALTDEMENSCRSTKYKMCSENAEKSPGNKRTVKQKQRTKSKDSIDKDQLDVGQSKDGNMSHIAQKKLQRNSDRNTEECEEKRNNRISKKQMPSMGSKNSTKKDKEESKKKRFSS 204
23 -12.400PF08551.10; RBL19_ARATH/44-142; Eukaryotic integral membrane protein (DUF1751 topsan)  ali follow..  17  6........................................................PFAWNLITSGYFELSV-YGVVFSTVSLLFMGKFLEPVWGSTEFLKFIFVVNFLTYLCVF-----------VTAIALYYITRLEVYLYMPFAGFHGVLAGLL............................................................................................................................................................................................... 94
24 -12.200PF05432.11; D2GX57_AILME/17-317; Bone sialoprotein II (BSP-II)  ali follow..  8  28.............................................................................................................................................................................................................SLYKHAYFYPPLKRFPVQSSSDSSEEDGNGDSSEEEEEEEETSNEEENNEENANSDENEDEESEAENTTLTATPGYGEETTPGTGYIGLAAIQLPKKSGDIGHKATKEEESDEEEEEDEENEENEAEVDENGQGINGTSSNST 170
25 -12.100PF03064.16; U79_HHV6Z/6-234; HSV U79 / HCMV P34  ali follow..  9  93....................................................................................................................................................................................................................TSISQNTEGRERILTVSHENGKLQITFVTIAKVSSEPELRNLGDLKFMEKFEKECRALDRKKHDDEHRKRSGKQKEKRKVEDIDKKKEDEKRKQEEKKRNDEDKRPDKKDEFDEPPKEKRQKSHHETKRNLEEQSH 228
26 -12.100PF15623.6; F7G021_CALJA/1-281; Cancer/testis gene family 47  ali follow..  12  103.....................................................................................................................................................MVAAARHYPIVGFRLQFL--------DMVHNFLHRIYH---------NDHILIRFRGSRLMVGPHPVMPSSDEPPLLVSERLGAGARAPESDDLGLIEEAEVVPEPEVPANLVEMAREPEEEPAEEAAEGKPSGEEPAEEAVPKAATEEPASAEEPATQEAAAPEEVTKYQYEKWDEEVQGAAGEEEKEQGKEKDA... 281
27 -12.000PF06524.12; B7QNY2_IXOSC/1-301; NOA36 protein  ali follow..  9  217.......................................................................................................................................................................................................................................................................GFETQQTKDLSMSTRHHSYGRQAMSSGRDDDEDDGYDYGGAGYYGSGGGGGDLDDEDEDDDEDDDDDDDDEDEESDEDESSDEKE 301
28 -12.000PF15231.6; F7IG15_CALJA/1-142; Variable charge X/Y family  ali follow..  7  1..................................................................................................................................................................................................................MAPKKRASGPPAKAGETRKRKSSSEASPSTPKKKPQMPKEGKRGKAGPGGRGRKKRAAGEKMAAVGAPEAGSGPAPPGPSKPRSQELPPQELPPCQPVSEPDPLSQETQLEDPLNQETQLEEPLSDETQLEDPLRQET 138
29 -11.900PF15140.6; ERIC5_MOUSE/95-251; Domain of unknown function (DUF4573 topsan)  ali follow..  10  17...................................................................................................................................................................................................................GGECEQPQPGGKDDMLGTEEVKKDVEARTEVPSLKGDAEIKPLRLSSERDSPGAPQAGTMKFLQTAENILPLETTQELPPKEATGKGAQPQILEAIPKENSSPEIEGIQSAESSGQQQLVEAPGEAEQPQALETVLK 153
30 -11.800PF12361.8; A5KDR7_PLAVS/546-849; Duffy-antigen binding protein  ali follow..  8  169...................................................................................................................................................................................................................SNSSDGTSSATGDTTDAVDREINKGVPEDRDKTVGSKDGGGEDNSANKDAATVVGEDRIRENSAGGSTNDRSKNDTEKNGASTPDSKQSEDATALSKTESLESTESGDRTTNDTTNSLENKNGGKEKDLQKHDFKS. 304
31 -11.500PF00865.18; G5BSU2_HETGA/21-302; Osteopontin  ali follow..  7  1..........................................................................................................................................................................................................................................QADSGSSEEKPLYNKLPEAVSSWLKPDPSQKQNLLAPQNSVSSEETDDLKQETLPSNSNESHDHMDDVDDEDDGDQDSVDVDDDDHPDDSHHSDESDHSDESDEVVTDAPTNGP 114
32 -11.500PF05395.12; W5N4Y1_LEPOC/11-190; Protein phosphatase inhibitor 1/DARPP-32  ali follow..  7  25...................................................................................................................................................................................................................VEMIRRRRPTPATLFRVSDNPSPEEEHISHQWVVGENGILKPKRSNPCVYHPPSLRAVQRMAQAHMQALGASPPLEDPPEGVESEDGPPEAEMCEDSPCTPAESPEETKSDPESGAFDEQQDPLLTGSEVTTEEEAV 161
33 -11.500PF12429.8; Q4CVZ4_TRYCC/733-962; Protein of unknown function (DUF3676 topsan)  ali follow..  9  1....................................................................................................................................................................................................................TDVSIASEPRSEESTASHEELTEDDTDEQEEGIVNDLLLAASSSKADAGSSVPESATAAQSAENSHQEDNAQFHQGKTAQQFTLNEAKESMQRDSDVQPQDPQPAELTEVTDVEMSPESNDTEQPEEEGEANDRSD 136
34 -11.300PF01254.18; M3YT59_MUSPF/1-131; Nuclear transition protein 2  ali follow..  7  3.........................................................................................................................................................................................................................TKTQSLPNTHTQPHSNSRPQSHTCGPCTCSSHCQACGQSCGRSQSCSRSRSSSQSPTGRQGQSPYPSPPPRRQKHTMYSHHRPPRPTAHSCSYSKNRKNLEGKVNKRKVAKRSQQVYKTKRRSSGRKYN.. 131
35 -11.300PF05177.12; G3TIA9_LOXAF/230-330; RCSD region  ali follow..  11  1........................................................................................................................................................................................................................................................RSMGSEEKPPLRRTSSMIETREEKGRAAEEAKHGEKAAEHSADKEPQSPAQGEAAEPETSSPKAENGPGTPTEETMAGEEVETEKSAEVKEERAENEEDK 100
36 -11.100PF05793.12; T2FA_XENLA/2-524; Transcription initiation factor IIF, alpha subunit (TFIIF-alpha)  ali follow..  9  91........................................................................................................................................................KVDDQPWIL-------AGRKYKGVKKGGVTENASYFIFTQCADGAFEAFPVSNWY-NFTPVAKHRTLTAEEAEQEWERRNKVLNHFTIMQQRRLKDQVGDEDEDEEGGGKLEKGGKGKKKKKKSDLKIHDLEDDLELSSTESENSDEEGESRKKPQKKVPAKGGKKKKRKSDDEALEDSDDGDFEGQEVDYMSDES 283
37 -11.100PF07382.11; A0A0E9ASG6_CHLTH/1-221; Histone H1-like nucleoprotein HC2  ali follow..  3  1.................................................................................................................................................................................................................MLGVQKKRSTRKTAARKTVVRKPAAKKTAAKKAPVRKVAAKKTVARKTVAKKTVAARKPVAKKATAKKAPVRKAVAKKTVARKTVAKKTVAARKPVAKKATAKKAPVRKVAAKKTVARKTVAKKTVAARKPVAKKATAK 139
38 -11.000PF15234.6; F7EVW8_CALJA/35-269; Linker for activation of T-cells  ali follow..  9  99...................................................................................................................................................................................................................RDSDGANSVPSYENEEPACEDADEDEDEDDYHNPGYLVVLPDSAPAASTAAPPAPALSTSGLRDSAFSMESVDDYVNVPESGESAEASLDGSREYVNVSQELHPGVAKMEAATLSSQEAEEVEEEGAPDYENLQELN 235
39 -11.000PF14303.6; H6QQL9_PUCGT/205-361; No apical meristem-associated C-terminal domain  ali follow..  10  7.......................................................................................................................................................................................CCYNLLST-----------SPKW--------------HEYNISMDKKHEVKKATNPNPSSPLPGFLPSSTPADTTRGTSEASEDESTQQEPTRPIGRKKAKIAYQEEKLDASNHEHLKKMAGAHVDIAEAVKNQKNAISAQQSALERLADEAIMSKDLTGADEDV 146
40 -10.900PF05403.11; Q25876_PLAFA/1-212; Plasmodium histidine-rich protein (HRPII/III)  ali follow..  5  78...................................................................................................................................................................................................................AHHAADAHHAHHAADAHHAHHAADAHHAHHAAYAHHAHHAADAHHAHHASDAHHAADAHHAAYAHHAHHAADAHHAHHASDAHHAADAHHAAYAHHAHHAADAHHAADAHHATDAHHAHHAADAHHATDAHHAAD.. 212
41 -10.900PF15419.6; F1SKZ7_PIG/7-194; Leukemia NUP98 fusion partner 1  ali follow..  5  67......................................................................................................................................................................................................................................PVLPRLMSSDSHPRRHSYEDQGFRSCTHMRDYRKRSGDGSFKEPLESKERSHSKIQAFSESFEQQLCFRTKRSVSLGPESRKERNEKECWRLEMRSHKKVEERRSSRKEELGEAYIPA 184
42 -10.900PF12440.8; G1RGE8_NOMLE/5-95; Melanoma associated antigen family N terminal  ali follow..  10  1...................................................................................................................................................................................................................................................................QKSKLRAREKRHQARCENQDLGATQATVAEGESSSSAYLLFGDRPQNLPAAETPSMPEVLQGAPSTTNAIAPVSCTSSNEGASSQDEKS 89
43 -10.800PF03363.13; EBNA5_EBVB9/331-504; Herpesvirus leader protein  ali follow..  5  2...................................................................................................................................................................................................................GDRSEGPGPTRPGPPGIGPEGPLGQLLRRHRSPSPTRGGQEPRRVRRRVLVQQEEEVVSGSPSGPRGDRSEGPGPTRPGPPGIGPEGPLGQLLRRHRSPSPTRGGQEPRRVRRRVLVQQEEEVVSGSPSGPLRPRPR 138
44 -10.800PF06959.11; F1PAG8_CANLF/622-825; RecQ helicase protein-like 5 (RecQ5)  ali follow..  8  67...................................................................................................................................................................................................................REPPSQPCGLQDEDCSKALPGPRAEAPGSSFHCGGSSPEKTGKSPSKGGPLAKARASKKQQLLAAAALKDSQNITRFCLRAKSPSPLTSAPGAEDAGPGPSCEGMRGPPAAPEKCAGEEDGALGCLAAHPQTKECTR 203
45 -10.700PF05438.12; Q1T735_ORYLA/6-232; Thyrotropin-releasing hormone (TRH)  ali follow..  8  40...................................................................................................................................................................................................................AESLLLRSLLKKMQDEDDINDGVYAQQDWMAKRQHPGKRYREDLEKRQHPGRREEDEDEEYLNAQKRQHPGKREDEIQSSMGLQKRQHPGKRFLTGHISDNPIIMLGELSKRQHPGKRYLVLQSKRQHPGKRYQDDE 176
46 -10.700PF06390.12; GNAS3_MOUSE/1-257; Neuroendocrine-specific golgi protein P55 (NESP55)  ali follow..  7  1..................................................................................................................................................................................................................MDRRSRAQQWRRARHNYNDLCPPIGRRAATALLWLSCSIALLRALASSNARAQQRAAQRRSFLNAHHRSAAAAAAAQVLPESSESESDHEHEEVEPELARPECLEYDQDDYETETDSETEPESDIESETEIETEPETE 138
47 -10.700PF09309.10; E7FFL3_DANRE/676-947; FCP1, C-terminal  ali follow..  13  117...................................................................................................................................................................................................................EQPGPSRRKRQPSMSETMPLYTLCKEDLDSMDKEVDDILGEESDNESEGKGKAGRIEEEEEEVRPHTSKQKPPATDHIPPLAAVVEETSQTSTSEVCVTENVLRGHKRKLEEAREDEDKDEEDGDSSKDSNEDDEGS 253
48 -10.700PF05501.11; A7VLV8_9VIRU/140-263; Domain of unknown function (DUF755 topsan)  ali follow..  6  59..........................................................................................................................................................................................................................................................................................QQIQQAAPQRKRKNTYPHSKTRKKKTKRSRNVSSHSAKKIHGKSHHKTPTSSSSYSSSTSSSSPSS 124
49 -10.700PF05466.12; F6R3X8_HORSE/2-233; Brain acid soluble protein 1 (BASP1 protein)  ali follow..  10  32...................................................................................................................................................................................................................EEGTPKENETQAAAETTEVKEGKEEKPEKDAQDAANKPEDKEGEKDADAAKEDAPKAEPEQTEGAAEGKPEPPKDAKDGEQEQAAASGPAAGGDAPKASEAEAPAEPAPTKVDDKSKEGGEPTKTEAPAAPAAQETK 168
50 -10.600PF15772.5; G5CBI0_HETGA/104-332; UPF0688 topsan family  ali follow..  12  1.................................................................................................................................................................................................................LAGGVRSSARLRARSCSADIVAPVQDVAGSTSPKTACLTSSHKAPDRRTSKKFKSDKGHLVKAELQKLVSKGNSAALPEVVPRAPCKDSSAEGSALLPGSDSTAPARQEAAALPHSGCRCANDTVPAKTEDSQSPPEPC 139
51 -10.600PF05937.11; APC_HUMAN/2670-2843; EB-1 Binding Domain  ali follow..  10  30...................................................................................................................................................................................................................DNQAKQNVGNGSVPMRTVGLENRLNSFIQVDAPDQKGTEIKPGQNNPVPVSETNESSIVERTPFSSSSSSKHSSPSGTVAARVTPFNYNPSPRKSSADSTSARPSQIPTPVNNNTKKRDSKTDSTESSGTQSPKRHS 166
52 -10.600PF12406.8; Q8WPH8_THEAN/26-124; Surface protein  ali follow..  7  4............................................................................................................................................................................................................................................................LNPIDFDPNDDQHPLDPDQLIDQIEPSEQPAQQEPIEPQQPTQPSTEPEELQPETVTVEVPEPVTSEEPKESDQTEEQKHEEPEASPAPEPVDEPA 99
53 -10.500PF17069.5; RSRP1_RAT/1-300; Arginine/Serine-Rich protein 1  ali follow..  7  1..................................................................................................................................................................................................................MSSAAVSKYVNDMWPGSPQEKASPSTSGSGRSSRLSSRSRSRSSSRSSRPHSRSSSRSSSRSHSRPRRSRRSRSRSRSRRRHQRKYRRYSRSYSRSRSRSRGHRYYRDSRYEQPRRYYQSPSPYRSRSRSRSRGRSHH 138
54 -10.500PF04684.13; A7TQF6_VANPO/3-609; BAF1 / ABF1 chromatin reorganising factor  ali follow..  8  90...................................................................................................................................................................................................................NNNTSHSNQNIGTGTGTGTDSNNNNNIDFQSQLDGLNVVQNLHHQHQVGDEDDEDDVTKNVIVDVKDENIDHNGNSNNINDNRTNSNEIKKDTNNSNNDENVEDENENDSRDHNDEKPTTNTTTSTSTASTKYEDSG 226
55 -10.500PF15377.6; I2FUU7_USTH4/11-237; Domain of unknown function (DUF4604 topsan)  ali follow..  8  82...............................................................................................................................................................................................................KHLSHDEALQLKTASKGQPEEQKEGAKGKDQNIASTASALGARKRRGPIGEAADESKGLGEDVSISDIVNTAELIEKPSREKGKGNGTSKGGLKDVKDLIRKERDARAPTKTDKEQHKDDKSKEKIAAAKKLKAKSGKGLS 222
56 -10.400PF12619.8; G8Y0S6_PICSO/43-190; Mini-chromosome maintenance protein 2  ali follow..  6  50.............................................................................................................................................................................................................................................................DDEEYEEMDLSARRRIDEQLDKRDKLFQGTKGARSRGQAFLDDEDDTMEEVDEYGLPVQRRRRRRYDDTQEDELGDMDVDPFSEELSLESLSDIK 144
57 -10.400PF13825.6; O89325_CDVO/4-312; Paramyxovirus structural protein V/P N-terminus  ali follow..  7  172...................................................................................................................................................................................................................KPDRAADVSMLMEEELSALLRTSRNVGIQKRDGKTLQFPHNPEGKTRDPECGSIKKGTEERSVSHGMGIVAGSTSGATQSALKSTGGSSEPSVSAGNVRQPAMNAKMTQKCKLESGTQLPPRTSNEAESDSEYDD.. 306
58 -10.400PF12782.7; A1DWS9_STRPU/1-291; Invertebrate innate immunity transcript family  ali follow..  2  148...................................................................................................................................................................................................................GHRQGPPQDRPEEQPFGQRNESSDEDGRPHPRHHGRHHQHHHRNHTEGHQGHNETGDHPHRHHNKTGDGDQDRPMFEMRPFRFNPFGRKPFGDRPFGRRNGTEEGSPRRDGQRRPYGNRGRWGENESEEKEHPTTES 284
59 -10.400PF14585.6; O25262_HELPY/269-333; CagY type 1 repeat  ali follow..  12  1........................................................................................................................................................................................................................................................................................ETSKKTQQHSPQDLSNEEATEANHFENLLKESKESSDHHLDNPTETQTNFDGDKSEEITDDSNDQ... 65
60 -10.300PF12316.8; G3PRZ5_GASAC/498-683; Segment polarity protein dishevelled (Dsh) C terminal  ali follow..  9  25.................................................................................................................................................................................................PLPHPGAAPWPITLPYQFPVLHPYDMQQPGHGGPGAGSAGSQNSVINIPSNSSKGSSGSNCSKNEGRKSGGSGSEPEIRSHRAPSERSAAPPSERSVRSSVSHRSAHSHSIAFGPGLVYGPPGLPPQPPLSTAAPGAPPGRELASVPPETASRQS 180
61 -10.200PF15762.5; G1P4D6_MYOLU/1-188; Domain of unknown function (DUF4691 topsan)  ali follow..  8  2........................................................................................................................................................................................................................ASAGTERRPGAQEGTAEGTAEGPAQLSEAPRGHVQSSECPVMGDQGLVSAHEVCGTQGEDKRPTGPVSEPELQEERPKLEEERLKPEVEALEERGPRPMASVVRSSHGPKRKPVNLPGPSHQAHPRAEAELP 133
62 -10.200PF04774.15; M1BTZ0_SOLTU/158-266; Hyaluronan / mRNA binding family  ali follow..  6  6...................................................................................................................................................................................................................................................................DRRSGTGRGNEFIKREGSGRGNWGTTADDIAPVTEESVNDGEKIVDAEKQSGQEDAGDTNKDSSAAEPEEKEPEEKEMTLEEYEKVMEE 94
63 -10.200PF15240.6; G3RTV7_GORGO/1-150; Proline-rich  ali follow..  3  1..........................................................................................................................................................................................................MLLILLSVALLALSSAESSSEDVSQEESLFLISGKPEGRHPQGGNQSQGPRPPPGKPQGPPPQGGNQSQGPPPHPGKPERPPPQGGNQSQGPPHRPGKPEGPPPQGGNKSRPQGPPPAGGNPQQPQAPPAGKPQGPPPPPQGGRPP 146
64 -10.100PF05558.12; I1NLL8_ORYGL/3-193; DREPP plasma membrane polypeptide  ali follow..  8  59...................................................................................................................................................................................................................PPEIKALLKDKKTASKIKKNGPAVTKFLEELAKIDFPGAKPVSDAVAKSGTTPLSPAIAFILEKVAPFVPKEEPKPEPEAEAAAETTSREVAVEEEKKEEEAAPAEPAAAAAEAAAPSTEVVEEKKEEEKPAE.... 191
65 -10.100PF12300.8; RHLB_XANCP/377-551; ATP-dependent RNA helicase RhlB  ali follow..  5  1...................................................................................................................................................................................................................EQKIPVEPVTTELLTPLPRTPRATVEGEEVDDDAGDSVGTIFREAREQRAADEARRGGGRSGPGGASRSGSGGGRRDGAGADGKPRPPRRKPRVEGEADPAAAPSETPVVVAAAAETPAVTAAEGERAPRKRRRRRN 137
66 -10.100PF00499.20; K9Z3G3_CYAAP/22-166; NADH-ubiquinone/plastoquinone oxidoreductase chain 6  ali follow..  8  11....................IVYSAFLLGGVFLSISGLYILLNADFV--------------AAQILIYVGAINVLILFAIMLVNKTEVYQQVRGRLIRQVSTALVCVGLFALLGTMVLATPWQLSET--------SPAVVENTIVAIGKHFFSDYLLPFEIASVLLLMA-------MVGAII...................................................................................................................................................................... 144
67 -10.100PF15303.6; M4AJ82_XIPMA/1-279; E3 ubiquitin-protein ligase Arkadia N-terminus  ali follow..  10  115.........................................................................................................................................................................................................SSPSSSLRFGDSDTLSSDDEGEAGATGGQQKAPALPPGGGAAVGLRPSLGRTRGSRSHKWVRPEPEPVLLKRPCLSSRRPPHRKRFVKMAPGGGQRTQKQKERLLLQRKKREVIARRKYALLHSTSSSSKELSSDSSSASSTEAEDE 261
68 -10.000PF15808.5; G1TCX2_RABIT/1206-1418; BCL-6 co-repressor, non-ankyrin-repeat region  ali follow..  7  1....................................................................................................................................................................................................GLH-PKKQR-LRERWEQQVSAAENKGARQSRKEVTQALPSEVTIQGNDISEEKASRKRTEAKGNRSWSEESLKSSDNEQGSLPRTSLSSTNASGKKQTQPSCTPASRLPARQPRLKESPKPDVLCTDEDEGCPAASLLQKYPDHSEKPS... 157
69 -10.000PF15327.6; E9QB91_DANRE/1356-1525; Tankyrase binding protein C terminal domain  ali follow..  6  4................................................................................................................................................................................................FPETSTALLDTSVLRGRVRLNQKSTRRAPPSRAARHSALLTQVPEGPRDDEWRFRDSTEEKADSFKEAEESDSEEQAKGIETRTSSMSQPQRVALFPGMDPSALKAQLKKRGDSDNQTDGPSPSQLSRSPKSPFLPRAAPRVLPPAGGKENGEESS 159
70 -10.000PF16601.5; H0XAD4_OTOGA/548-737; Rabosyn-5 repeating NPF sequence-motif  ali follow..  10  43...................................................................................................................................................................................................................SPCSAQEPVQIWSGPPVLGQEFLPQSSISQQDEVPSLNPFDEEDFSSPTEEATASAPATELSSGPSAYIPKVYNPFEEEEEEEAAPFTHPDSPVPNPFDEEDEHPHPRSSSPLVPGNPFEEPTCTNPFEVDSDSGPE 179
71 -9.910PF07263.11; G1T1W8_RABIT/1-489; Dentin matrix protein 1 (DMP1)  ali follow..  5  350...................................................................................................................................................................................................................SDSSQEDNLSVPSSSESQSREEQADSDSNESLKSSEESPETTEEENSSSQEGLQSQSESAESPSEESQSEQDSQSDEGAGSDSQENSKSKEDSNSTESMSSSEEDGQARGMDMESRKLTVDTYNNKPIGDQDDNDCQ 486
72 -9.810PF02063.17; W5NK27_LEPOC/2-285; MARCKS family  ali follow..  8  139...................................................................................................................................................................................................................KKTKKETGEGAENDGAASTDEGKDEAAATPGAADAAEEGKPAQEEAKDEAAAAVEEAKEEASPSQEAKSEEAAPEQAAAEEPKAAPAAEEPKAKEESVAEEKPAEPAAAETKAAPAAEQEAPKAEEPASATQEPAPA 275
73 -9.810PF18004.1; H0EIK8_GLAL7/868-1046; 26S proteasome regulatory subunit RPN2 C-terminal domain  ali follow..  13  32..........................................................................................................................................................................................................................................................QEVKTDEAPTLIATAVLSTTAQAKRRAQKKERAQRRESMDIDQTPTTPKVNAPSEKMDVDEEAKDKEDKSEEKKEGTDAEKEISATESAKKKLEKEKV 129
74 -9.810PF16322.5; G3WUT0_SARHA/29-239; Tubby N-terminal  ali follow..  12  75.............................................................................................................................................................................................................................RSAKRSPAAGATAAGGQGGISKKEKKGKPKGNDGFFSDDEPDPNVQILTVGRSGSSRSLAEAAAAGGQHSSKQDLRATMQTKGISSSMNFDEEEEEEEEDEEEEDSSSSSQLNTNARPGSATSKKSN 201
75 -9.770PF09595.10; VGLG_HMPVC/35-217; Metaviral_G glycoprotein  ali follow..  10  1.................................................................................................................................................................................................................LIGITTLSIALNIYLIINYTIQKTSSESEHHTSSPPTESNKEASTISTDNPDINPNSQHPTQQSTENPTLNPAASVSPSETEPASTPDTTNRLSSVDRSTAQPSESRTKTKPTVHTRNNPSTASSTQSPPRATTKAIRR 139
FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 3 1 9   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Ye Y, Godzik A. Multiple flexible structure alignment using partial order graphs. Bioinformatics. 2005 Mar 3;